Chemomab Therapeutics Ltd (CMMB)
0.71
-0.18
(-20.11%)
USD |
NASDAQ |
May 08, 16:00
0.71
0.00 (0.00%)
After-Hours: 19:02
Chemomab Therapeutics Cash from Investing (TTM): 25.59M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 25.59M |
March 31, 2023 | 31.58M |
December 31, 2022 | 19.53M |
September 30, 2022 | -9.398M |
June 30, 2022 | -20.47M |
March 31, 2022 | -42.80M |
Date | Value |
---|---|
December 31, 2021 | -45.19M |
September 30, 2021 | -25.61M |
June 30, 2021 | -20.63M |
March 31, 2021 | -0.054M |
December 31, 2020 | -0.062M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-45.19M
Minimum
Dec 2021
31.58M
Maximum
Mar 2023
-7.955M
Average
-9.398M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Compugen Ltd | -- |
Pluri Inc | 12.36M |
BioLine Rx Ltd | 1.444M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | 1.951M |